Cycled Testosterone Therapy to Improve Physical Function in Frail Nursing Home Residents
Public ClinicalTrials.gov record NCT02679274. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Frailty is a recognized cause for disability, hospitalization, and mortality in nursing home residents. Testosterone treatment is among the potentially beneficial treatments in addition to resistance exercise for improving muscle strength and mass in frail adults. The investigators have demonstrated that cycled administration of testosterone improves muscle mass and strength in healthy adults. It is proposed that cycled testosterone administration may be an effective adjuvant therapy for frail older men and women during rehabilitation programs. The hypothesis is that testosterone treatment in addition to standard-of-care (SOC) rehabilitation will result in improved muscle mass and physical function when compared to patients receiving SOC only. Therefore, in a randomized, double-blind, placebo controlled study, the investigators will test the effects of cycled testosterone administration (2 week on treatment, 2 weeks off treatment) on body composition and physical function in male and female nursing home residents undergoing rehabilitative care. Primary outcomes will be assessed before and after 10 weeks of treatment using bioelectric impedance, handgrip dynamometers, short physical performance battery (SPPB), and quality of life (QOL) questionnaires. Data from this pilot project will become the foundation for the development of a larger long-term project solicitation to the NIH aimed at elucidating the efficacy of testosterone treatment on physical function and independence in frail older adults.
Study identification
- NCT ID
- NCT02679274
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2016
- Primary completion
- Sep 19, 2016
- Completion
- Sep 19, 2016
- Last update posted
- Feb 17, 2019
2016
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gulf Health Care Center | Galveston | Texas | 77555 | — |
| Gulf Health Care Center | Texas City | Texas | 77590 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Aging trials
Other public records listing Aging. Sorted by last update posted; newest first. Not a recommendation.
- NCT06879626: Effect of Snacks on Aging Active, not recruiting
- NCT06501820: Neural Control of Gait & Navigation in ADRD Recruiting
- NCT07731451: The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging Not yet recruiting
- NCT07719088: Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life Not yet recruiting
- NCT07719049: Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study Recruiting
- NCT07461584: Memory Enhancement in Aging With Optimal Dosing Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02679274, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2019 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02679274 live on ClinicalTrials.gov.